GLENMARK PHARMA RECEIVES USFDA APPROVAL FOR FINGOLIMOD CAPSULES, 0.5 MG

Highlights

• USFDA has given green signal for the production of Fingomolid Capsules that are used in treatment of relapsed form of multiple sclerosis in adults

• At present, Glenmark's portfolio comprises of 164 products authorized for distribution in the US market

• Shares of Glenmark Pharma saw intraday high of Rs 411.20 on the BSE

Glenmark Pharmaceuticals, world’s leading phar....